But that’s our role as shareholders to help fund teams/projects
I supported the cap raise at 17c - the purpose of that raise was to advance RP-11/platform to market - was expecting the ramp up of staff.
We help sow into their opportunity to do some really important/exciting science - and PYC/patients has the opportunity to reap rewards/hope if successful.
Worth remembering the probability of success is not affected by the mood of the market/share price, but the determination/ /efforts and quality of output by the team of 70.
Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS, page-62
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |